NIAID PROFESSIONAL, SCIENTIFIC AND TECHNICAL SUPPORT SERVICES (PSTSS)
ID: 75N93024R00013Type: Solicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH NIAIDBETHESDA, MD, 20892, USA

NAICS

All Other Professional, Scientific, and Technical ServicesT (54199)

PSC

SUPPORT- PROFESSIONAL: OTHER (R499)
Timeline
    Description

    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking proposals for Professional, Scientific, and Technical Support Services (PSTSS) through a Request for Proposal (RFP). The primary objective of this procurement is to secure specialized expertise in scientific research, vaccine development, and laboratory operations within biohazard environments, with a total estimated contract value of up to $3 billion over a performance period from June 1, 2025, to May 31, 2030. This initiative is crucial for advancing public health objectives, ensuring that sensitive information is safeguarded and that all work is performed independently by the contractor. Interested parties must submit their proposals by December 16, 2024, and are required to be registered in the System for Award Management (SAM). For further inquiries, potential offerors can contact Rosemary Gomes at Rosemary.Gomes@nih.gov or Kristel Turansky at Kristel.Turansky@nih.gov.

    Files
    Title
    Posted
    The document serves as an amendment to the Request for Proposals (RFP) 75N93024R00013, issued by the National Institute of Allergy and Infectious Diseases (NIAID). It provides clarifications to various inquiries regarding the solicitation for Professional, Scientific, and Technical Support Services. Key instructions include that offerors must create their own Excel workbooks based on Attachment 10 as no template will be provided, and that all labor categories must be included in the offeror's overhead. The government reiterates that hours listed are for evaluation purposes only and that the project director is the only key personnel required. The document also emphasizes that any travel, materials, or subcontracting considerations will be addressed at the Task Order level, and all task orders must adhere to the defined timelines with an average turnaround of 14 calendar days. The amendment ensures all terms remain unchanged and highlights the importance of strict compliance with guidelines and requirements. The ultimate goal is to select qualified proposals for effective contract execution to support NIAID initiatives within specified regulatory frameworks.
    This document is Amendment Number 002 to RFP 75N93024R00013, issued by the NIH for Professional, Scientific, and Technical Support Services. It addresses queries from potential offerors related to proposal submissions, detailing requirements for various attachments, proposal structure, and clarification on any conflicting instructions. Notably, it emphasizes the necessity of including past performance information and financial capacity evidence in business proposals. Questions regarding the inclusion of travel costs, subcontractor commitments, and the need for specific forms and structures are also resolved, ensuring all submissions follow the defined guidelines. The amendment confirms the evaluation criteria, underscoring the distinction between corporate experience and past performance information, and affirms that all proposals must adhere strictly to the outlined regulations without the possibility of revisions to key terms. The proposal due date remains unchanged. Overall, the document illustrates the government's effort to streamline the proposal process while ensuring adherence to regulatory standards and requirements for potential contractors.
    The document is an amendment to an RFP (Request for Proposal) issued by the National Institute of Allergy and Infectious Diseases (NIAID) for Professional, Scientific, and Technical Support Services (PSTSS). It addresses inquiries from potential offerors regarding submission requirements and clarifies various sections of the RFP, specifically around proposal formatting, content, and evaluation criteria. Key points include the confirmation that personnel resumes, particularly for Key Personnel, do not count against the technical proposal's 50-page limit and that corporate experience should be included in the Technical Proposal, while Past Performance information belongs in the Business Proposal. The document emphasizes the distinct requirements for Technical and Business Proposals, the importance of acknowledging receipt of amendments, and the necessity for offerors to adhere to specified formats for their submissions. As the final amendment, it delineates the critical deadlines and reaffirms the original terms of the solicitation remain unchanged, which is essential for ensuring compliance and understanding the proposal evaluation process. Overall, the amendment provides essential guidance for bidders to prepare compliant proposals in competition for the NIAID contract.
    The document is an amendment concerning RFP Number 75N93024R00013, titled "NIAID Professional, Scientific, and Technical Support Services (PSTSS)." Issued by Kristel Turansky and Rosemary Gomes as contracting officers, the amendment provides clarifications and key information regarding proposal submissions for a multi-award Indefinite Delivery Indefinite Quantity (IDIQ) contract, with a total ceiling value of $3 billion. Potential offerors were reminded of the importance of submitting a Proposal Intent Response Sheet for government planning, although it’s non-binding. The document specifies a deadline for proposals of December 16, 2024, and emphasizes that all terms of the original solicitation remain unchanged, ensuring that the acknowledgment of this amendment is crucial for the validity of submitted proposals. In summary, this amendment aims to clarify aspects of the solicitation while maintaining the original proposal deadline, encouraging participation while emphasizing the significance of compliance with administrative requirements within the contracting process.
    The government document outlines a Request for Proposal (RFP) issued by the National Institute of Allergy and Infectious Diseases (NIAID) for professional, scientific, and technical support services. The primary objective is to secure expertise in scientific research, vaccine development, and laboratory operations within specific biohazard environments. The contract is structured as a Multiple Award Indefinite Quantity contract with an estimated total value of up to $3 billion, covering a performance period from June 1, 2025, to May 31, 2030. Interested parties must submit proposals by December 16, 2024, and must be registered in the System for Award Management. Key aspects include precise invoicing requirements, security clearance protocols for personnel, and compliance with privacy regulations. The contract stipulates that all work be independently performed by the contractor, ensuring no personal services are rendered. The document emphasizes the importance of safeguarding sensitive information and mandates detailed reporting of costs and performances throughout the contract duration. Overall, this solicitation illustrates the government's initiative to procure specialized scientific services necessary for advancing public health objectives.
    Lifecycle
    Similar Opportunities
    In Vitro Assessments of Antimicrobial Activity
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking proposals for the In Vitro Assessments of Antimicrobial Activity program to support in vitro testing for evaluating the therapeutic potential of compounds against infectious diseases. This initiative aims to enhance the understanding and treatment of infectious diseases by providing efficient assessment tools integrated into the product development pipeline, focusing on various pathogens including bacteria, fungi, viruses, and challenging pathogens that require innovative culturing techniques. The RFP will be available online around December 30, 2024, and proposals must be submitted via the NIAID electronic Contract Proposal Submission (eCPS) platform; interested parties can contact Alexander Beraud at alexander.beraud@nih.gov or Brian Madgey at brian.madgey@nih.gov for further information.
    2026 NIAID DMID Omnibus Broad Agency Announcement
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH) and specifically the National Institute of Allergy and Infectious Diseases (NIAID), is soliciting proposals for the 2026 DMID Omnibus Broad Agency Announcement (BAA) aimed at advancing research and development of medical countermeasures against antimicrobial-resistant pathogens and viruses with pandemic potential. The BAA encompasses two primary research areas: the development of therapeutics, vaccines, and diagnostics for antimicrobial-resistant bacterial and fungal pathogens, and the creation of direct-acting antivirals for viral families of pandemic potential. This initiative is critical for addressing public health challenges related to infectious diseases and enhancing biodefense capabilities. Proposals for Research Area 001 are due by February 21, 2025, while those for Research Area 002 are due by January 21, 2025. Interested parties can reach out to primary contact Swee L. Teo at teosl@niaid.nih.gov or 240-669-5173 for further information.
    Chemistry, Manufacturing and Controls and Related Services for Development of Drug Products
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is soliciting proposals for Chemistry, Manufacturing, and Controls (CMC) services related to the development of drug products. The objective of this procurement is to secure high-quality formulated drug products to support preclinical, IND-enabling, and clinical studies, ensuring compliance with current Good Manufacturing Practices (cGMP). This initiative is critical for advancing therapeutic development and enhancing the drug development pipeline, which is vital for public health. Proposals are due by February 3, 2025, with a contract period extending from September 30, 2025, to July 31, 2031, and a maximum funding amount of $49,885,703. Interested parties can reach out to Michelle Cecilia at michelle.cecilia@nih.gov or Valerie Whipple at valerie.whipple@nih.gov for further information.
    A--Biomedical Computing Support Services
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for Biomedical Computing Support Services to assist in ongoing cancer research initiatives. The procurement aims to provide comprehensive computing services that facilitate the analysis of high-dimensional biomedical data, supporting both domestic and international studies within the Division of Cancer Epidemiology and Genetics (DCEG). This opportunity is critical for enhancing cancer research capabilities, with an estimated contract value ranging from $3,000 to $147 million over a performance period of five years, beginning September 16, 2025, with a potential five-year extension. Interested offerors must submit their proposals by January 6, 2025, and can direct inquiries to Antoinette C. Robinson at antoinette.robinson@nih.gov or by phone at +1 240 276 5823.
    NIAID Virology Quality Assurance
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking proposals for a comprehensive quality assurance program for virologic assays related to HIV and other viral pathogens. The objective is to ensure the validity and comparability of laboratory data through proficiency testing panels and real-time assay controls, which are critical for ongoing and future studies on infectious diseases. This program has been operational since 1988 and supports approximately 110 laboratories globally, emphasizing the importance of maintaining high standards in virologic testing. Proposals are expected to be submitted electronically via the NIAID electronic Contract Proposal Submission (eCPS) website, with the solicitation anticipated to be available on or about January 9, 2025. For further inquiries, interested parties can contact Shawnice Williams at shawnice.williams@nih.gov or Ashley Kinderdine at ashley.kinderdine@nih.gov.
    Pathology Support for the National Institute of Environmental Health Sciences
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is soliciting proposals for pathology support services for the National Institute of Environmental Health Sciences (NIEHS) under solicitation number 75N96025R00003. The procurement aims to secure comprehensive pathology-related services, including technical support, histopathological evaluations, and assistance with reporting and publication of findings, with a contract period anticipated from July 2025 to July 2026, and options for extensions up to July 2035. This initiative is crucial for enhancing NIEHS's research capabilities while ensuring compliance with federal regulations regarding human subjects and promoting inclusivity in research practices. Interested parties must submit their proposals by 4:00 PM EST on January 6, 2025, and can direct inquiries to Sue McKenzie at sue.mckenzie@nih.gov or Erica Kitzmiller at erica.kitzmiller@nih.gov.
    National Institute of Environmental Health Sciences (NIEHS) Assessment of Immunotoxicity – In Vitro and In Vivo Assessment of Immune Function
    Active
    Health And Human Services, Department Of
    The National Institute of Environmental Health Sciences (NIEHS), part of the Department of Health and Human Services, is seeking proposals for a federal contract focused on the assessment of immunotoxicity through in vitro and in vivo evaluation of immune function. The objective is to provide comprehensive research services to evaluate how selected test agents may modulate immune responses, utilizing both established and innovative methodologies to reduce animal use in toxicology studies. This contract, anticipated to be a cost-plus-fixed-fee type, is expected to be awarded by September 2025, with a base period of one year and nine optional one-year extensions. Interested parties should direct inquiries to Adam Muhsin at adam.muhsin@nih.gov and monitor the Sam.gov website for the solicitation release, which is expected no sooner than 15 days from this notice.
    Solicitation Notice - Operation and Management of the Mali Service Center
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for the Operation and Management of the Mali Service Center (MSC) under a Total Small Business Set-Aside contract. The selected contractor will provide comprehensive operational support for NIAID-funded research projects in Mali, including project management, financial oversight, and logistics support, while ensuring compliance with both U.S. regulations and local laws. This contract, which spans from February 27, 2025, to February 26, 2030, has a budget range of $10,000 to $45 million and requires proposals to be submitted electronically by January 16, 2025. Interested parties can reach out to primary contact Sevag Kasparian at Sevag.Kasparian@nih.gov for further information.
    Ongoing Monoclonal Antibodies and Plasmids Services through GENSCRIPT
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), intends to negotiate a sole-source contract with GenScript USA Inc. for ongoing monoclonal antibodies and plasmids services. The procurement aims to support the NIAID Laboratory of Immunogenetics (LIG) in advancing research on human B cells and the isolation of monoclonal antibodies, which are critical for developing new vaccine candidates against influenza. This contract is a continuation of existing services that require continuity for accurate comparison of results, and interested parties may submit capability statements via the NIAID electronic Simplified Acquisition Submission System (eSASS) by January 3, 2025, at 5:00 PM ET. For further inquiries, contact Dana Monroe at dana.monroe@nih.gov or call 406-375-9814.
    A--Clinical Research Operations and Management (CROMS)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is soliciting proposals for the Clinical Research Operations and Management Services (CROMS) contract. This procurement aims to enhance the oversight and efficiency of clinical studies by providing essential systems, tools, and expert resources for data management, site monitoring, and regulatory compliance. The contract is crucial for ensuring high-quality research while adhering to strict federal regulations regarding human subjects, data privacy, and security protocols. The performance period is set from September 30, 2025, to September 29, 2026, with options extending through 2030. Interested parties can reach out to Natalie Bruning at natalie.bruning@nih.gov or Tara C. Knox at knoxt@nhlbi.nih.gov for further details.